Polaris Market Research recently published a research report on “Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2020 – 2027” in its research database.
According to the research report, the global active pharmaceutical Ingredient (API) market size & share was valued at USD 177.4 Billion in 2019 and is expected to reach USD 306.1 Billion By 2027, growing at a CAGR of 7.1% during the forecast period.
What is Active Pharmaceutical Ingredient (API)? How Big is the Active Pharmaceutical Ingredient (API) Market?
Active pharmaceutical ingredient (API) is a component in any medication that provides the required impact on the body to treat a condition. APIs are produced from raw materials. It is the primary component of a pharmaceutical drug. APIs are divided into two types – synthetic and natural. Synthetic chemical APIs form a large part of the pharmaceutical market. Very small drugs associated with these forms are commercially available in the market.
Factors such as the increasing diseased population, rise in infectious diseases, and growing prevalence of harmful diseases are driving the growth of the active pharmaceutical ingredient (API) market. Also, developments in active pharmaceutical ingredient (API) manufacturing are promoting the market’s growth.
Request Sample Copy of Active Pharmaceutical Ingredient (API) Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market/request-for-sample
Key Aspects Covered by Report:
- Analysis and research of the global active pharmaceutical ingredient (API) market status and future forecast, involving production, revenue, consumption, historical, and forecast.
- Key manufacturers along with their production, revenue, market share, and recent development.
- Breakdown data by regions, type, manufacturers, and applications
- Qualitative and quantitative analysis of the global market
- The global and key regions market potential and advantage, opportunity, challenge, drivers, restraints, and risks.
- Competitive developments such as expansions, agreements, new product launches, and acquisitions in the global market.
Some of the Top Market Players Are:
- AbbVie Inc.
- Albemarle Corporation
- Aurobindo Pharma
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Cipla Inc.
- Reddy’s Laboratories Ltd.
- ELI Lilly and Company
- Hoffmann-La Roche
- GlaxoSmithKline PLC
- Lonza Group
- Merck & Co. Inc.
- Mylan N.V.
- Novartis AG Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd.
To Know More About More Market Players, Request Brochure of this Report@ https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market/request-for-sample
Active Pharmaceutical Ingredient (API) Market: Growth Drivers
A supportive government guideline for API production coupled with changes in geopolitical situations is fueling the market expansion. Rising initiatives by governments of many countries to promote the production of API is expected to escalate the adoption of active pharmaceutical ingredient (API). Increasing focus on precision medicine and increased importance of generics are expected to boost the market growth. A surge in technological developments, which has led to enhanced market players’ capabilities and manufacturing skills, is propelling the growth of the global active pharmaceutical ingredients (API) market.
Moreover, an increasing number of strategic initiatives, such as new drug and biological product launches, acquisitions, collaborations, and regional expansions, are augmenting the market growth of active pharmaceutical ingredients (API). Also, the adoption of organ-on-chip models in drug development acts as a catalyst for the growth of the APIs market. The rising geriatric population in developing nations and growing healthcare expenditure are positively impacting the market’s growth.
Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/6701
Active Pharmaceutical Ingredient (API) Market: Report Scope
|Market Outlook for 2027||USD 306.1 Billion|
|Market Size 2019 Value||USD 177.4 Billion|
|Expected CAGR Growth||7.1% from 2020 – 2027|
|Forecast Year||2020 – 2027|
|Top Market Players||AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd|
|Segments Covered||By Product Type, By Form, By Manufacturer Type, By Application, By Region|
|Customization Options||Customized purchase options are available to meet your research needs. Explore customized purchase options|
Segmentation Insight by Product Type
- High potent active pharmaceutical ingredient segment flourished the market growth in 2019
Based on product type, the global active pharmaceutical ingredient (API) market is segmented into monoclonal antibodies, insulin, peptide hormones, blood factors, immune-globulin, cytokines, peptide antibiotics, vaccines, small molecule antibiotics, HPAPI, and others. High potent active pharmaceutical ingredient segment accounted for a significant market share in 2019. High potent APIs are helpful in the treatment of respiratory disorders, treatment of cancer, and hormonal imbalances. Monoclonal antibodies and vaccines are further expected to record a prominent market share in the market over the forecast period.
Segmentation Insights by Application
- Cardiology segment held the largest revenue share in the market
On the basis of application type, the global active pharmaceutical ingredient (API) market is segmented into Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others. Among all, cardiology accounted for the largest market share in 2019, owing to the increasing prevalence of cardiovascular diseases across the globe.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market/inquire-before-buying
(Inquire a report quote OR available discount offers to the sales team before purchase.)
North America dominated the market with the highest revenue share
Based on geography, North America held the largest revenue share in the global active pharmaceutical ingredient (API) market. The key factors contributing to the market’s growth include growing investment in R&D and advancements in drugs due to rising indications of diseases. Further, as per the U.S. Food and Drug Administration (FDA), only 28 percent of active pharmaceutical ingredients in the country are manufactured within the U.S.
Europe is anticipated to show significant growth in terms of CAGR. This growth can be attributed to the local presence of the key market players and the rising strategies employed by them.
Moreover, Asia Pacific is anticipated to generate one of the fastest growth in terms of CAGR in the global active pharmaceutical ingredient (API) market due to the increasing initiatives by the government for the production of critical drugs. Also, rising R&D and a growing aging population in nations like Japan, China, India, and others in this region.
Browse the Detail Report “Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2020 – 2027” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
For Additional Information OR Media Enquiry, Please Mail Us At: firstname.lastname@example.org
- In August 2021, Teva Pharmaceutical and MEDinCell received approval from the U.S FDA for a new drug application to treat schizophrenia.
- in November 2019, Bio-Techne announced an investment of over USD 40 million to upgrade its protein manufacturing facility and meet cell therapy demands.
Some of The Key Questions from Our Customers Are:
- Which are the top players in the global market?
- How will the market change in the next years?
- What are the drivers and restraints of the market?
- Which regional market will show the highest growth?
- What will be the CAGR and size of the market throughout the forecast period?
- Which area offers the most significant benefit for the world market?
- What are the likely advanced scenarios and maximum incentives to see movement by application, type, and region?
Polaris Market Research has segmented the Active Pharmaceutical Ingredient market on the basis of product type, form, manufacturer type, application and region
Active Pharmaceutical Ingredient Product Type Outlook (Revenue – USD Million, 2016 – 2027)
- Monoclonal Antibodies
- Peptide Hormones
- Blood Factors
- Peptide Antibiotics
- Small Molecule Antibiotics
- Highly Potent Active Pharmaceutical Ingredient (HPAPI)
Active Pharmaceutical Ingredient Form Outlook (Revenue – USD Million, 2016 – 2027)
- Non-Aqueous Liquid
- Dry Powder
Active Pharmaceutical Ingredient Manufacturer Type Outlook (Revenue – USD Million, 2016 – 2027)
Active Pharmaceutical Ingredient Application Outlook (Revenue – USD Million, 2016 – 2027)
- CNS & Neurology
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
30 Wall Street
New York City, NY 10005,
Phone: +1-929 297-9727